Kabarec Financial Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Kabarec Financial Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$30K	Buy	+11,000	New	+$31.9K	0.02%	61

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kabarec Financial Advisors's FCSC Position: Q2 2018 in Review

Kabarec Financial Advisors opened a new position in Fibrocell Science Inc. (FCSC) in Q2 2018: 11,000 shares worth $30K. The stake represents 0.02% of the portfolio and ranks #61 among its holdings.

25 funds tracked by Wall St. Rank hold FCSC as of Q2 2018.

Kabarec Financial Advisors held 11,000 shares of Fibrocell Science Inc. worth $30K as of Q2 2018.
Fibrocell Science Inc. was a new Kabarec Financial Advisors position in Q2 2018.
Fibrocell Science Inc. made up 0.02% of Kabarec Financial Advisors's portfolio in Q2 2018, its #61 holding.
25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2018.

Based on Kabarec Financial Advisors's 13F filing for Q2 2018, filed 9 Aug 2018.